Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

AstraZeneca hails EU approval of Tezspire for rhinosinusitis form

22nd Oct 2025 09:53

(Alliance News) - AstraZeneca PLC on Wednesday said its drug Tezspire has been approved in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps. Read More

LONDON BROKER RATINGS: Goldman raises IAG; Peel Hunt raises XP Power

22nd Oct 2025 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

AstraZeneca hails US FDA approval for Tezspire for rhinosinusitis form

20th Oct 2025 08:49

(Alliance News) - AstraZeneca PLC on Monday said its lupus drug Saphnelo received a positive opinion from the European Medicines Agency's committee for medicinal products for human use for a new subcutaneous formulation. Read More

LONDON BRIEFING: B&M cuts profit view; Astra drug gets FDA backing

20th Oct 2025 07:58

(Alliance News) - B&M European Value Retail cuts its profit guidance following an accounting error and says Chief Financial Officer Mike Schmidt will step down, while Bank of Ireland and Secure Trust Bank may increase provisions linked to the UK motor finance redress scheme. AstraZeneca announces a drug approval in the US. Read More

Daiichi, AstraZeneca report breast cancer gains with Enhertu, Datroway

20th Oct 2025 03:44

(Alliance News) - Daiichi Sankyo Co Ltd on Sunday reported promising clinical activity across multiple oncology programmes, including early signals in solid tumours and new data in breast cancer. Read More

Amgen and AstraZeneca says US FDA broadens indication for Tezspire

17th Oct 2025 21:44

(Alliance News) - Amgen Inc and AstraZeneca on Friday said the US Food & Drug Administration had broadened the indication for Tezspire to a second disease. Read More

AstraZeneca's Saphnelo gets nod in EU for systemic lupus erythematosus

17th Oct 2025 20:08

(Alliance News) - AstraZeneca PLC on Friday said Saphnelo subcutaneous self-administration has been recommended for approval in the European Union for systemic lupus erythematosus. Read More

AstraZeneca says Imfinizi lowers mortality risk in bladder cancer

17th Oct 2025 14:02

(Alliance News) - Astrazeneca PLC on Friday said that adding its Imfinzi drug to the treatment of bladder cancer was linked to lower mortality rates. Read More

LONDON MARKET OPEN: Stocks slump on US credit worries

17th Oct 2025 08:35

(Alliance News) - Stock prices in Europe traded sharply lower on Friday, with sentiment souring at the end of the week, and declines on the FTSE 100 were largely broad-based. Read More

LONDON MARKET MIDDAY: FTSE underperforms, pound shakes off tepid data

16th Oct 2025 12:15

(Alliance News) - Stocks in London struggled on the back of a tepid UK gross domestic product reading, but peers in Europe made strides and equities in New York are set to open higher. Read More

LONDON BROKER RATINGS: AstraZeneca cut; Barclays raises Centrica

16th Oct 2025 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON MARKET MIDDAY: Luxury and gold shine as UK worries dim London

15th Oct 2025 12:08

(Alliance News) - Federal Reserve rate cut expectations lifted stock market sentiment on Wednesday, but the FTSE 100 missed out on the rally, as some of its heavyweights traded lower. Read More

LONDON MARKET CLOSE: Miners prosper as FTSE 100 makes steady progress

13th Oct 2025 17:07

(Alliance News) - The FTSE 100 recouped some of Friday's hefty losses, while gold soared once more, as Donald Trump dialled down his rhetoric in the trade spat between the US and China. Read More

UPDATE: AstraZeneca confirms deal with US government on drug prices

13th Oct 2025 09:35

(Alliance News) - AstraZeneca PLC on Monday confirmed it has reached a "historic" drug pricing agreement with the Donald Trump administration in the US. Read More

LONDON BRIEFING: Lloyds Banking Group ups motor finance provision

13th Oct 2025 08:00

(Alliance News) - Lender Lloyds Banking Group has set aside another GBP800 million related to motor finance matters, Oxford Instruments reports a tariff hit first half and Serica Energy has agreed a deal with BP to acquire North Sea assets. Read More

Trump announces deal with AstraZeneca on drug prices, tariffs

13th Oct 2025 07:09

(Alliance News) - US President Donald Trump announced a deal with AstraZeneca PLC on Friday that he said would lead to significantly lower domestic drug prices in exchange for granting the pharma giant tariff relief. Read More

PRESS: Trump strikes drug-pricing deal with AstraZeneca - MSNBC

10th Oct 2025 20:48

(Alliance News) - President Donald Trump on Friday plans to announce an agreement with the pharmaceuticals firm AstraZeneca PLC to lower drug prices in the US, MSNBC reported, citing a White House official. Read More

AstraZeneca ups investment at new Virginia facility to USD4.5 billion

9th Oct 2025 18:02

(Alliance News) - AstraZeneca PLC on Thursday said it will increase investment at its new Virginia manufacturing facility by USD500 million, bringing its total pledge to USD4.5 billion. Read More

AstraZeneca touts positive results in trial for hypertension therapy

7th Oct 2025 08:40

(Alliance News) - AstraZeneca PLC on Tuesday said its therapy for hypertension demonstrated positive results in a recent phase 3 trial, while its breast cancer therapy is put forward for review in Japan. Read More

LONDON MARKET MIDDAY: UK construction confidence remains weak

6th Oct 2025 12:01

(Alliance News) - Stock prices in London were mostly lower at midday on Monday, while data published by S&P Global showed that the UK construction sector's decline slowed in September. Read More

FTSE 100 Latest

Value9,527.65

Change20.24